According to the target of monoclonal or epstein-barr virus ebna-1

HIGHLIGHTS

• who: (IL- et al. from the Centre de Recherche en Cancu00e9rologie et Immunologie Nantes-Angers (CRCINA), UMR966, Tours, France have published the research work: According to the Target of Monoclonal or Epstein-Barr Virus EBNA-1, in the Journal: Cancers 2020, x of /2020/
• what: The authors report that auto-antibodies specific for GlcSph were detected in the serum of 49.3% MGUS/SMM and 38.9% MM patients, and that GlcSph was targeted by the monoclonal Ig in 16.8% MGUS/SMM and 14.4% MM cases. Working with purified monoclonal Igs allowed the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.